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Summary 
Streptococcus pyogenes strains producing pyrogenic exotoxin A (scarlet fever toxin) have recently 
caused episodes of streptococcal toxic-shock-like  syndrome (TSLS). We exploited knowledge 
of genetic diversity and relationships among exotoxin A-producing patient strains provided by 
multilocus enzyme electrophoresis to select strains for comparative sequencing of toxin genes. 
Our analysis identified four alleles of speA in natural populations,  one of which (speAl) occurs 
in many distinct clonal  lineages and is probably  old.  Two other alleles (spe.A2 and speA3), 
characterized solely by single amino acid substitutions,  were each identified in single clones that 
together have caused the majority of TSLS episodes. It is unlikely that these alleles have had 
a long association with S. Ivogenes  clones. A fourth allele (speA4)  also is present  in a single 
phylogenetic lineage  and is 9%  divergent from the other three toxin alleles. An absence of 
synonomous (silent) nudeotide changes in speA2 and speA3 is unusual and suggests that the 
allelic  variation is not selectively  neutral, which implies that the toxins are not functionally equivalent. 
These results may be important in helping to understand the recent increase in frequency and 
severity of disease caused by S. pI,  ogenes. 
U 
'nusually severe  infections caused by Streptococcuspyogenes 
have been reported with increasing  frequency in the 
United States in recent years (1, 2). Many patients have soft 
tissue infections, such as ceUulitis or fasciitis, but some indi- 
viduals have experienced  deeper infections, including osteomye- 
litis, myometritis, sepsis, and meningitis. This has led to the 
description  of a  streptococcal  toxic-shock-like  syndrome 
(TSLS). 
Severe invasive  S. t~ogenes infections have also been reported 
in Canada (3), the United Kingdom (4), Denmark (5), Sweden 
(6), and Norway (7). There is evidence that most or all of 
the increase in frequency of severe episodes in the United 
Kingdom, certain other European countries, and the United 
States occurred in the 1980s (4, 6, 8), and has been caused 
by strains that express M protein serotypes 1 or 3 (4, 8, 9). 
Taken together, the data indicate that the frequency of un- 
usually severe infections caused by strains of S. tvogenes  ex- 
pressing only a few of the ~>80 recognized M protein sero- 
types has increased on an intercontinental scale  in recent years. 
A recent analysis by multilocus enzyme electrophoresis of 
103 epidemiologically  unassociated S. tvogenes  isolates cul- 
tured from patients with severe  infections in the United States 
revealed that nearly half the disease episodes and more than 
two-thirds of the cases of TSLS were caused by strains of 
two related clonal genotypes (10). The great majority of iso- 
lates of these two clones, which have been designated as elec- 
trophoretic types 1 and 2 (ET 1 and ET 2), produced M pro- 
teins of serotype 1 and 3, respectively (10). The same study 
also confirmed an earlier report (11) of a relatively high fre- 
quency of expression of streptococcal pyrogenic exotoxin A 
(SPE A) (scarlet fever toxin) among isolates from TSLS pa- 
tients.  The demonstration of this association both within 
clones and among distantly related clones supported the hy- 
pothesis  that SPE A, which is encoded by the spe.A gene, 
is a causal factor in the pathogenesis of TSLS. This observa- 
tion was particularly important because none of 80 S. ~o- 
genes strains isolated from a variety of clinical sources in the 
United States between 1976 and 1986 produced SPE A (1), 
whereas many isolates recovered earlier in this century from 
patients  with severe scarlet fever expressed this exotoxin. 
SPE A, which is bacteriophage  encoded, is a member of 
a family of "superantigen" toxins synthesized by S. D,  ogenes 
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acid  homology and  share  functional  activities,  induding 
pyrogenicity,  enhancement of susceptibility  to  endotoxic 
shock, and enhancement of delayed hypersensitivity to in- 
duced skin rashes (12). These toxins also stimulate prolifera- 
tion of murine and human lymphocytes bearing particular 
TCR VB gene products and induce donal anergy in T cells, 
either by clonal deletion or functional inactivation (12). 
Because epidemiologic and toxicologic evidence indicates 
that expression of SPE A  is a causal factor in the etiology 
of many cases of TSLS (10), scarlet fever (13), and rheumatic 
fever (14), we undertook the present project to study the mo- 
lecular population genetics of the speA gene in greater detail. 
Here we report the nucleotide sequences and clonal distribu- 
tion of four alleles of spe.A in strains of S. tTogenes recovered 
from patients with severe invasive diseases. 
Materials and Methods 
Bacterial Isolates.  A sample of 10 strains of S. ~ogenes (Table 
1) was drawn from a collection of 108 isolates recovered from pa- 
tients with severe streptococcal diseases in the United States in the 
period 1986-1990 (10). The strains are representative of seven dis- 
tinetive clones that carry the speA gene (10). In addition, we studied 
nine isolates recovered in the 1980s from patients living in Yugo- 
slavia (n  =  2), the United Kingdom (n  =  2), France (n  =  2), 
Germany (n = 2), and New Zealand (n =  I); and a patient isolate 
recovered in Germany in the 1970s. 
All but three of the strains (MGAS 251, MGAS 256, and MGAS 
262) expressed levels of SPE A detectable by Ouchterlony im- 
munodiffusion  with hyperimmune  rabbit antiserum prepared  against 
purified exotoxin A (11). 
Sequencing ofspeA.  The speA gene of each of the 20 isolates 
was amplified  by PCR, with synthetic oligonucleotides,  as described 
previously (10). The portion sequenced (708 bp) represents 94% 
of speA and encodes virtually the entire mature protein. 
Estimating Genetic Relationships among Clones.  Methods of es- 
timating genetic relationships among S. ~ogenes clones by mul- 
tilocus enzyme dectrophoresis have been described (10). The ET 
designations are cognate with those used previously (10). 
Results and Discussion 
Clonal Relationships among Multilocus Enzyme Genotypes. 
The electrophoretic types of the 10 United States isolates were 
presented earlier (10). The multilocus enzyme allele profiles 
of strains  MGAS  480  (Yugoslavia),  MGAS  492  (United 
Kingdom), and MGAS 496 (Germany) were identical to that 
recorded previously for isolates of ET 1, and the allele profiles 
of MGAS 485 (Yugoslavia),  MGAS 491 (United Kingdom), 
and MGAS 495  and MGAS 624  (Germany) were identical 
to that of ET 2 (10). The profiles of MGAS 493 and MGAS 
494 (France) were identical and were designated as ET 14a 
because they differ only slightly from the profile of ET 14 
(10). MGAS 500, which was recovered from a patient in New 
Zealand with scarlet fever, was assigned to ET 3a (Table 1). 
Estimates of the genetic relationships among the isolates are 
shown in Fig.  1. 
Alleles speA1, speA2, andspeA3.  The sequences of the PCR- 
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amplified 708-bp segment of the speA gene from five isolates 
(MGAS 500, MGAS 327, MGAS 165, MGAS 167, and MGAS 
156), representing ET 3a, ET 4, ET 5, ET 16, and ET 20, 
respectively, were identical to a published sequence (15) of 
spe.A and will be referred to as the speA1 allele (Table 1). This 
allele also occurred in strains MGAS 493  and MGAS 494, 
representing ET 14a. The sequences of all seven isolates  of 
ET 1 (four of which expressed serotype M1 protein) were 
invariant and differed from the published sequence by a single 
transition (G-*A) at nucleotide site 328,  which results in 
a Gly --* Set substitution at amino acid position 110 (spe.A2). 
Similarly, the speA sequences of all five isolates of ET 2 were 
identical and differed from the published sequence by one 
base change (G-*A)  at  nucleotide 316,  which specifies  a 
Val--~Ile replacement at amino acid 106 (speA3). 
Interestingly,  these mutations occur in a segment consisting 
of five amino acids (residues 86-90 in the numbering system 
used in reference 12) that are highly conserved in the aligned 
sequences of staphylococcal enterotoxin serotype A (SEA), 
staphylococcal enterotoxin serotype B (SEB),  SEC1,  SEC3, 
SED, SEE, and streptococcal pyrogenic exotoxin C. For ex- 
ample, the valine residue at amino acid 106 (15) in the deduced 
sequence of the SPE A1 protein is fully conserved in these 
seven exotoxins, and a glycine residue occurs at amino acid 
110 (15) in all sequences except that of SED (12). It is also 
noteworthy that the segment of SPE A containing the varia- 
tions we have detected is located immediately adjacent to a 
region containing cysteine residues that are involved in for- 
mation of a disulfide loop that is believed to be required for 
mitogenicity ofSPE A and other bacterial superantigens (16). 
Grossman et al. (16) have suggested that an intact disulfide 
linkage is required for interaction of toxin with the TCR, 
but not with MHC class II molecules. It is, therefore, rea- 
sonable to conclude that the three toxin variants may display 
qualitative or quantitative heterogeneity in one or more of 
the functions ascribed to SPE A. 
Allele speA4.  In striking contrast to the relative homo- 
geneity of the speA sequences in the other 19 isolates,  the 
sequence of the single isolate of ET 26 (MGAS 262) showed 
a large number of nucleotide substitutions. Compared with 
speA1, there were 67 nucleotide differences (91% nucleotide 
identity) that produce 26 amino acid changes (89%  amino 
acid similarity) (data not shown). Although the nucleotide 
changes  are  distributed  in  a  seemingly  random  pattern 
throughout the structural gene, almost all of them occur in 
regions encoding amino acids that are not highly conserved 
when SPE A is aligned with the SEA through SEE, and SPE 
c/12). 
Distribution of speA Alleles among Clonal Lineages.  In the 
small sample of strains  examined, all seven strains of ET 1 
(four of which expressed serotype M1 protein) had the speA2 
allele, and all five ET 2 strains carried sloeA3 and expressed 
protein serotype M3 (Table 1). In contrast, the speAl  allele 
was identified in strains of six distinct clonal lineages, some 
of which are highly divergent in overall chromosomal genomic 
character (Fig. 1). The spe.A4 allele occurred in a single strain 
that was the most divergent multilocus enzyme genotype 
(ET 26)  in a large sample of spe.A-containing  strains (10). 
Exotoxin A Gene Table  1.  Propem'es  of 20 Isolates of S. pyogenes Representing Nine ETs 
M  protein 
ET  Strain  serotype  sped allele  Locality 
1  250  NS*  speA2  California 
1  251  NS  speA2  California 
1  256  NS  speA2  California 
1  285  M1  speA2  Colorado 
1  480  M1  speA2  Yugoslavia 
1  492  M1  speA2  United Kingdom 
1  496  M1  speA2  Germany 
2  158  M3  speA3  Nebraska 
2  485  M3  speA3  Yugoslavia 
2  491  M3  speA3  United Kingdom 
2  495  M3  speA3  Germany 
2  624  M3  speA3  Germany 
3a  500  M49  speA1  New Zealand 
4  327  M2  speA 1  Arizona 
5  165  NT*  speA1  Minnesota 
14a  493  M3  speA1  France 
14a  494  M3  speA  1  France 
16  167  M66  speA1  Texas 
20  156  M18  speA1  Nebraska 
26  262  NT  speA4  California 
*  NS, not studied. 
* NT, nontypable. 
I  I  I 
I  I  I 
.60  .40  .20 
Genetic distance 
M  protein  Exotoxin  A 
ET  serotype  allele  I 
1  1  speA2 
2  3  speA3 
3a  49  speA1 
4  2  speA 1 
5  speA 1 
14a  3  speA 1 
1 6  6 6  speA 1 
20  18  speAl 
2 6  speA4 
I 
0 
We have previously hypothesized (10) that the presence 
of the identical sped sequence in strains with highly differen- 
tiated chromosomal genotypes is a consequence of bacteri- 
ophage-mediated horizontal transfer and recombination. The 
occurrence of the speAl allele on several diverse chromosomal 
backgrounds and the restriction, in our sample, ofspeA2 and 
speA3 to single clonal lineages can be interpreted as evidence 
that the latter two alleles are evolutionarily younger than 
speA1. An alternative,  but not mutually exclusive, hypoth- 
esis is that the spe.A1 allele has a greater dispersion velocity 
in natural populations. Thus, for example, this allele might 
be laterally transferred at a relatively high rate owing to dis- 
Figure 1.  Dendrogram of 9 S. tg~genes  ETs. Each isolate was character- 
ized by its combination of alleles at 12 enzyme loci, and distinctive mul- 
ti]ocus enzyme genotypes were designated as ETs. The dendrogram was 
generated from a matrix of genetic distances between pairs of ETs by the 
average linkage method (10). Strains are designated by the ET numbers 
given in Table 1. The DNA sequence data for spe.A2, speA3, and stmA4 
are available from  EMBL/GenBank/DDBJ  under  accession numbers 
X61554-X61573. 
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carries it. 
Because only a relatively small sample of isolates has thus 
far been analyzed for allelic variation in speA,  our observa- 
tions should not be interpreted to mean that  expression of 
the M1 protein serotype is confined to isolates of ET 1, or 
that all toxinogenic M1 isolates carry the speA2 allele. In this 
regard,  we note that  aUelic heterogeneity in metabolic en- 
zyme genes has been observed among isolates expressing the 
same M protein serotype (see Fig.  1; and J. M, Musser, un- 
published data).  Therefore,  additional large-scale  studies of 
aUelic variation in speA among toxinogenic strains of known 
multilocus enzyme genotype will be required to fully delineate 
the strength of clone-toxin allele-M protein serotype associa- 
tions present in natural populations of S. pyogenes. These studies 
are in progress. 
Inasmuch as synonomous (silent) nucleotide changes out- 
numbered nonsynonomous changes by a factor of ~20  in 
a sample of 25 different bacterial genes (17),  it is a curious 
circumstance that the only mutations distinguishing the speA2 
and the speA3  alleles from the common speAl  allele result 
in amino acid replacements.  It is also noteworthy that both 
mutations occur in the same gene segment, adjacent to a re- 
gion that encodes a group of amino acids that is highly con- 
served in other bacterial superantigens (12). In addition, the 
ratio (1.3:1) of synonomous to nonsynonomous changes in 
speA4 also is unusually low. Taken together,  these observa- 
tions suggest that there are functional correlates of the allelic 
variation and that the alleles have been subject to natural se- 
lection.  This hypothesis is currently being tested by com- 
parative analysis  of purified toxin functions in murine  and 
human systems and in animal models of streptococcal patho- 
genesis.  Studies of this type may be particularly important 
in helping to explain temporal variation in the frequency and/or 
severity of disease  caused by this pathogen. 
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